COMMUNIQUÉS West-GlobeNewswire

GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
15/09/2026
FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocol Initiation of Phase 1 trial in MM patients contingent upon timing and receipt of non-dilutive grant [...]
AMA and Atalan Launch Collaboration to Advance Physician Retention Research
15/09/2026
CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) and Atalan today announced a new research collaboration focused on advancing understanding of the factors that influence physician [...]
Touro University Awards Shlomo Rechnitz Honorary Doctorate for Contributions to Healthcare and Philanthropy
15/09/2026
Recognition honors Rechnitz's longstanding commitment to healthcare, charitable giving, education, and community leadership LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Touro University has awarded Shlomo Rechnitz, [...]
Nice Healthcare Supports Employers with Launch of New Health Plan
15/09/2026
New offering pairs Nice Healthcare’s in-home and virtual primary care with clinician-led care navigation, powered by a partnership with Garner Health, to help employers fight rising premiums without cutting benefits [...]
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
15/09/2026
New program targets peripheral nerve regeneration and restoration of nerve function SCOTTSDALE, Ariz., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced the launch of APPB-429, a new gene therapy [...]
Clene Announces $4 Million Registered Direct Offering
15/09/2026
Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million registered direct [...]
SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit
15/09/2026
HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment Hydrafacial study shows improvements in skin hydration and overall skin quality following [...]
KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance
15/09/2026
The 184-patient milestone moves KORTUC's lead program toward readout, alongside a cervical cancer study with UC San Diego and newly authorized K-BOOST rectal cancer trial in France PALO ALTO, Calif., Sept. 15, 2026 ( [...]
New Imprivata Research Finds 72% of Healthcare Organizations Have AI Tools or Agents Deployed Without Formal IT Approval
15/09/2026
Survey of U.S. healthcare leaders reveals that AI adoption is accelerating, but unapproved deployments and fragmented identity security strategies create governance challenges WALTHAM, Mass., Sept. 15, 2026 (GLOBE [...]
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
15/09/2026
-- Leading multi-site OB/GYN health practice to implement FemVue ® for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- [...]
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
15/09/2026
Chaired by Mo Qatanani, PhD, Clinical & Scientific Advisory Board brings deep expertise in obesity, cardiometabolic disease and drug development Board will guide MitoRx's development strategy for lead asset MTRX31 [...]
Tria Federal Achieves CMMC Level 2 Certification, Affirming Its Ability to Protect Sensitive Federal Data
15/09/2026
Rigorous, independent audit confirms Tria's security controls meet the Department of War’s standard ARLINGTON, Va., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced that it has achieved Cybersecurity [...]
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
15/09/2026
LAS VEGAS, NV, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related [...]
Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing
15/09/2026
ERNA-201 demonstrated encouraging disease-modifying activity in the industry-standard collagen-induced arthritis model, providing meaningful proof-of-concept for Ernexa's engineered synthetic iMSC platform beyond [...]
Sienna Announces September Dividend
15/09/2026
MARKHAM, Ontario, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
PolyPid Announces Participation in Upcoming Fall Investor Conferences
15/09/2026
PETACH TIKVA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
15/09/2026
Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 million Company remains eligible for up to approximately $10 million in additional proceeds [...]
Dimenso Raises $650,000 to Bring Physical AI and Smart Glasses to Life Sciences Laboratories
15/09/2026
Boston-based company backed by Draper B1 and Next Tier Ventures is building AI infrastructure to capture, structure, and understand scientific work as it happens Dimenso has raised $650,000 from Draper B1 and Next Tier [...]
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
15/09/2026
CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today [...]

Pages